動物生技藥品市場規模、佔有率、成長分析（按類型、收入、目標疾病、來源和地區）- 產業預測，2025 年至 2032 年

預計 2023 年全球獸用生技藥品市場價值將達到 264.4 億美元，到 2032 年將成長至 386.5 億美元，預測期內（2025-2032 年）的複合年成長率為 4.31%。

隨著人們對動物健康的重視程度不斷提高以及飼主對寵物健康意識的不斷增強，獸用生技藥品市場正在經歷顯著成長。寵物擁有量的增加和畜牧業產量的上升進一步推動了該行業的擴張。通用感染疾病的增加凸顯了預防措施的必要性，並加強了對獸用生技藥品的投資。重組疫苗、DNA疫苗和單株抗體等下一代生技藥品以及先進的生物技術平台等技術創新正在改變這一格局。此外，改進的低溫運輸物流和向偏遠地區的廣泛推廣對於提高疫苗的可及性和有效性至關重要。總體而言，強力的政府措施和合作研發努力正在為家牛、家禽、伴侶動物和水產養殖等各個領域創造充足的成長機會。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與約束

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術分析
• 案例研究
• 顧客購買行為分析

動物生技藥品市場規模（按類型和複合年成長率）（2025-2032）

• 市場概覽
• 疫苗
• 抗生素
• 驅蟲藥
• 生長促進劑

動物生技藥品市場規模（按類型和複合年成長率）（2025-2032）

• 市場概覽
• 家畜
• 伴侶動物

動物生技藥品市場規模（按目標疾病和複合年成長率） (2025-2032)

• 市場概覽
• 細菌感染疾病
• 病毒感染
• 寄生蟲感染疾病
• 代謝紊亂

動物生技藥品市場規模（依來源及複合年成長率）（2025-2032）

• 市場概覽
• 細胞培養
• 去活化病原體
• 重組技術

動物生技藥品市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 按部門分類的公司佔有率分析
  • 收益同比對比（2022-2024 年）

主要企業簡介

• Hipra
• Zoetis
• Boehringer Ingelheim
• Tsinghua Tongda
• Bayer Animal Health
• Intervet
• Elanco Animal Health
• Ceva Animal Health
• Vetoquinol
• Beijing SVA Vaccines Serums
• Virbac
• Harbin Veterinary Research Institute
• Shenzhen Kangtai Biological Products
• Chongqing Zhifei Biological Products
• Merck Animal Health

結論和建議

Global Veterinary Biologics Market size was valued at USD 26.44 billion in 2023 and is poised to grow from USD 27.58 billion in 2024 to USD 38.65 billion by 2032, growing at a CAGR of 4.31% in the forecast period (2025-2032).

The veterinary biologics market is experiencing notable growth driven by heightened emphasis on animal health and the rising awareness among pet owners regarding their pets' wellbeing. Increasing pet ownership and livestock production further fuel this sector's expansion. The rise in zoonotic diseases underscores the need for preventive measures, enhancing investment in veterinary biologics. Innovations such as recombinant vaccines, next-generation biologics like DNA vaccines and monoclonal antibodies, and advanced biotechnological platforms are transforming the landscape. Additionally, improved cold chain logistics and extensive outreach to remote areas are crucial for enhancing vaccine access and efficacy. Overall, robust government initiatives and collaborative R&D efforts present ample opportunities for growth across various segments, including cattle, poultry, companion animals, and aquaculture.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Veterinary Biologics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Veterinary Biologics Market Segments Analysis

The veterinary biologics market is segmented into type, species, target disease, source, and region. By type, the market is classified into vaccines, antibiotics, Antiparasitic, and growth promoters. Depending on the species, it is bifurcated into livestock and companion animals. According to target disease, the market is divided into bacterial infections, viral infections, parasitic infections, and metabolic disorders. As per the supported source, it is categorised into cell culture, inactivated pathogens, and recombinant technologies. Regionally, it is analyzed across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Driver of the Global Veterinary Biologics Market

One of the key market drivers for the Global Veterinary Biologics Market is the increasing prevalence of zoonotic diseases that can be transmitted from animals to humans. As urbanization and human-animal interactions rise, the risk of such diseases escalates, prompting governments and healthcare organizations to prioritize animal health management. This, in turn, drives demand for vaccines and biologics that ensure the health and productivity of livestock and companion animals. Additionally, growing awareness among pet owners regarding animal health and the importance of preventive care further propels the market, as consumers seek effective solutions to protect their animals from infectious diseases.

Restraints in the Global Veterinary Biologics Market

One key market restraint impacting the global veterinary biologics market is the stringent regulatory environment governing the approval and commercialization of veterinary products. The complex and lengthy process for obtaining necessary certifications and licenses can delay market entry for new vaccines and therapeutics, hampering innovation and accessibility. Additionally, varying regulatory standards across countries may complicate international trade and distribution, limiting market potential for manufacturers. These challenges can create barriers for smaller companies and new entrants, fostering an environment where larger, established players dominate, ultimately stifling competition and reducing the overall growth potential of the veterinary biologics sector.

Market Trends of the Global Veterinary Biologics Market

The Global Veterinary Biologics market is experiencing a marked shift towards recombinant DNA and vector-based vaccines, reflecting an industry-wide trend favoring innovative and efficient solutions. This transition from traditional live and inactivated vaccines is driven by the advantages these novel technologies present, such as enhanced safety profiles, strain specificity, and rapid production capabilities, essential for addressing the challenges posed by emerging and mutating diseases. Investments from both established companies and startups in recombinant platforms are increasing, driven by advancements in cell culture and synthetic biology, ultimately aiming to meet the diverse health needs of both companion and large livestock animals.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Case Studies
• Customer Buying Behavior Analysis

Global Veterinary Biologics Market Size by Type & CAGR (2025-2032)

• Market Overview
• Vaccines
• Antibiotics
• Antiparasitic
• Growth Promoters

Global Veterinary Biologics Market Size by Species & CAGR (2025-2032)

• Market Overview
• Livestock
• Companion Animals

Global Veterinary Biologics Market Size by Target Disease & CAGR (2025-2032)

• Market Overview
• Bacterial Infections
• Viral Infections
• Parasitic Infections
• Metabolic Disorders

Global Veterinary Biologics Market Size by Source & CAGR (2025-2032)

• Market Overview
• Cell Culture
• Inactivated Pathogens
• Recombinant Technologies

Global Veterinary Biologics Market Size & CAGR (2025-2032)

• North America (Type, Species, Target Disease, Source)
  • US
  • Canada
• Europe (Type, Species, Target Disease, Source)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Species, Target Disease, Source)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Species, Target Disease, Source)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Species, Target Disease, Source)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Hipra
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tsinghua Tongda
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intervet
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beijing SVA Vaccines Serums
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Harbin Veterinary Research Institute
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Kangtai Biological Products
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chongqing Zhifei Biological Products
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations